Duke’s Most-Cited — The Scholars Other Scientists Look To
Congratulations to Dr. Barton Haynes, director of the DHVI.
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute has demonstrated wide protection against SARS-CoV-2 viruses and variants, including Omic
Federal Grant to Duke University School of Medicine Expands HIV Research
The Duke Human Vaccine Institute(DHVI) and the Department of Surgery at Duke University School of Medicine recei
Unraveling the Mysteries of the Immune System
In late 2019, as the world started to hear whispers of an emerging virus in China, Priyamvada Acharya, PhD, associa
Duke Human Vaccine Institute researchers study a pan vaccine for all types of coronaviruses.
Duke Human Vaccine Institute researchers are featured on the PBS NC series SCI NC and explain the work that goes into creating a vaccine that can protect us against all potential coronaviruses.
Closing in on an HIV vaccine using rare antibodies
A rare type of antibody found in some individuals could help develop an HIV vaccine to target highly diverse viral strains.
The Impact of Science: Duke Researcher Helps Develop Vaccines and Young Minds
Kevin Saunders explains the technology he used when COVID-19 hit, “We thought of creating a vaccine with properties that the current vaccines lacked.”
